IGFBP7 and glioma: The findings indicated that the enhanced pathways in C0 IGFBP7+ Glioma cells included inhibiting hydrolase activity, promoting cell-substrate adhesion, aiding in wound healing, inhibiting peptidase activity, and regulating cell-substrate adhesion.